Marielle de Locht

Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.

Y. Schneider, J. V. van Cutsem, H. W. Landuyt, 1993, The Journal of clinical investigation.

Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect.

R. Crichton, Y. Schneider, J. V. van Cutsem, 1994, Kidney international.